Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ocular Therapeutix, Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ocular Therapeutix, Inc since year 2005.
Table 2 shows the detailed insider transactions of Ocular Therapeutix, Inc since 2005.
The reporting company's ticker symbol is OCUL. The reporting company's CIK number is 1393434.
The total value of stock buying since 2005 is $13,886,546.
The total value of stock sales since 2005 is $72,398,505.
The total value of stock option exercises since 2005 is $656,149.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-14||Hanley Kevin F. (See Remarks)||Buy||10,000||5.50||55,000|
|2018-12-10||Hanley Kevin F. (SEE REMARKS)||Buy||10,000||5.60||56,000|
|2018-12-06||Bollag Daniel M (See Remarks)||Buy||17,400||5.76||100,224|
|2018-08-20||Mattessich Antony C. (President & CEO)||Buy||20,000||5.95||119,000|
|2018-08-14||Notman Donald (Chief Financial Officer)||Buy||12,500||6.29||78,625|
|2018-08-10||Mattessich Antony C. (President and CEO)||Buy||16,900||6.23||105,287|
|2017-12-21||Sawhney Amarpreet (Exec Chairman of the Board)||Option Ex||189,393||2.61||494,315|
|2017-12-12||Mattessich Antony C. (President and C.E.O.)||Buy||21,000||4.29||90,090|
|2017-12-07||Notman Donald (Chief Financial Officer)||Buy||4,800||4.00||19,200|
|2017-12-06||Bollag Daniel M (See Remarks)||Buy||24,700||3.93||97,071|
|2017-11-16||Sawhney Amarpreet (Exec. Chairman of the Board)||Buy||19,000||5.18||98,420|
|2016-12-15||Sawhney Amarpreet (President and CEO)||Buy||45,300||7.85||355,605|
|2016-08-05||Sawhney Amarpreet (President and CEO)||Option Ex||58,357||1.35||78,781|
|2016-06-09||Sawhney Amarpreet (President and CEO)||Buy||10,000||6.70||67,000|
|2015-11-17||Sawhney Amarpreet (President and CEO)||Buy||10,000||8.25||82,500|
|2015-09-15||Fortune James (Chief Operating Officer)||Sale||9,470||17.16||162,505|
|2015-09-14||Sawhney Amarpreet (President and CEO)||Buy||15,000||16.64||249,600|
|2015-06-15||Versant Side Fund Iii, L.p. (10% Owner)||Sale||320,000||22.00||7,040,000|
|2015-06-15||Warden Charles M (Director)||Sale||320,000||22.00||7,040,000|
|2015-06-10||Versant Side Fund Iii, L.p. (10% Owner)||Sale||427,000||22.00||9,394,000|
|2015-06-10||Sv Life Sciences Fund Iv Strategic Partners, L. P. (10% Owner)||Sale||1,119,000||22.00||24,618,000|
|2015-06-10||Warden Charles M (Director)||Sale||427,000||22.00||9,394,000|
|2015-05-13||Sawhney Amarpreet (President and CEO)||Option Ex||51,491||1.35||69,512|
|2015-02-27||Lindstrom Richard L Md (Director)||Option Ex||24,620||.55||13,541|
|2015-02-02||Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner)||Sale||500,000||29.50||14,750,000|
|2014-07-30||Ascension Health Ventures Ii, Llc (10% Owner)||Buy||153,846||13.00||1,999,998|
|2014-07-30||Ankerud Eric (See Remarks)||Buy||1,000||13.00||13,000|
|2014-07-30||Sawhney Amarpreet (President and CEO)||Buy||76,922||13.00||999,986|
|2014-07-30||Sv Life Sciences Fund Iv (gp), L.p. (10% Owner)||Buy||715,380||13.00||9,299,940|
Insider trading activities including stock purchases, stock sales, and option exercises of OCUL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ocular Therapeutix, Inc (symbol OCUL, CIK number 1393434) see the Securities and Exchange Commission (SEC) website.